Their parents, heterozygous carriers of pathogenic ATR variants, should also be monitored for cancer predisposition as it is done for heterozygous carriers of ATM pathogenic variant that cause ataxia-telangiectasia in a homozygous state [79–81]. The gene discussed is ATM; the disease is ataxia telangiectasia.